LifeMD Missed Expectations

LifeMD (LFMD) reported a loss of $0.06 per share on revenue of $62.22 million for the second quarter ended June 2025. The consensus estimate was a loss of $0.02 per share on revenue of $66.20 million. The Earnings Whisper number was $0.01 per share. The company missed expectations by 700.00% while revenue grew 22.81% on a year-over-year basis.

The company said it expects third quarter revenue of $61.0 million to $63.0 million and 2025 revenue of $250.0 million to $255.0 million. The company's previous guidance was 2025 revenue of $268.0 million to $275.0 million. The current consensus revenue estimate is $67.50 million for the quarter ending September 30, 2025 and revenue of $268.15 million for the year ending December 31, 2025.

LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings.